EFFICACY OF NILOTINIB IN EARLY CHRONIC PHASE CML PATIENTS WHO HAVE SUBOPTIMAL CYTOGENETIC OR MOLECULAR RESPONSE TO IMATINIB. A MULTICENTRIC RETROSPECTIVE STUDY

被引：0

作者：

Luciano, L. ^{[1
]}

Seneca, E. ^{[1
]}

Annunziata, M. ^{[2
]}

Pezzullo, L. ^{[3
]}

Danise, P. ^{[4
]}

Palmieri, F. ^{[5
]}

Iovine, M. ^{[6
]}

Vallone, R. ^{[7
]}

Pane, F. ^{[1
]}

机构：

[1] Univ Naples Federico II, Hematol Dept, Naples, Italy

[2] AORN Cardarelli, Hematol & Trasplantat Unit, Naples, Italy

[3] S Giovanni Di Dio & Ruggi DAragona Hosp, Hematol Unit, Salerno, Italy

[4] Umberto I Hosp, Oncohematol Dept, Nocera Inferiore, Italy

[5] San Giuseppe Moscati, Hematol Dept, Avellino, Italy

[6] AORN S Anna & S Sebastiano, Hematol Unit, Caserta, Italy

[7] G Rummo Hosp, Hematol Unit, Benevento, Italy

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1336

引用

页码：540 / 540

页数：1